公开(公告)号：US20170273917A1

公开(公告)日：2017-09-28

申请号：US15511033

申请日：2015-09-10

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Anthony FUTERMAN ,  Andres David KLEIN

IPC: A61K31/13 ,  G01N33/50 ,  A61K49/00 ,  C12Q1/68

CPC classification number: A61K31/13 ,  A61K9/0019 ,  A61K31/439 ,  A61K49/0004 ,  C12Q1/6883 ,  C12Q2600/112 ,  C12Q2600/156 ,  C12Q2600/158 ,  C12Q2600/178 ,  G01N33/50 ,  G01N33/5058 ,  G01N2800/28 ,  G01N2800/2842

Abstract: The present invention provides pharmaceutical compositions comprising at least one NMDA receptor antagonist for use in treating neuropathic forms of Gaucher Disease (nGD).